Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05797818 · ClinicalTrials.gov registry record · Phase 1
Red Light Photobiomodulation and Topical Disinfectants
A Phase 1 study, sponsored by Ondine Biomedical.
- Completed
- Registry status
- Phase 1
- Development phase
- 28
- Enrollment target
NCT05797818 is a Phase 1 study that has completed, run by Ondine Biomedical. The registered enrollment target is 28 participants.
The verdict
NCT05797818, a Phase 1 study, has completed, sponsored by Ondine Biomedical.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 28 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to evaluate the potential effects of photobiomodulation when used with topical disinfectants in the anterior nares of healthy adults. Over a three week period, participants will have their anterior nares swabbed with methylene blue, chlorhexidine gluconate, or a combination of the two followed by 4 minutes of non-thermal red light treatment. The fourth week of consist of only red light treatment. Culture samples of the subjects nasal microbiome will be taken prior to treatment, immediately after treatment, 4-, 8-, 24-, and 48 hours after treatment.
Interventions
- DEVICE Methylene Blue Only
- DEVICE Chlorhexidine Gluconate Only
- DEVICE Methylene Blue + Chlorhexidine Gluconate
- DEVICE Light Only
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2023-01-10 |
| Est. Completion | 2023-02-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05797818
The ClinicalTrials.gov registry entry for NCT05797818 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ondine Biomedical, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Methylene Blue Only is the first listed.
NCT05797818 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05797818 about?
NCT05797818 is a clinical study titled "Red Light Photobiomodulation and Topical Disinfectants". The goal of this clinical trial is to evaluate the potential effects of photobiomodulation when used with topical disinfectants in the anterior nares of healthy adults. Over a three week period, participants will have their anterior nares swabbed with methylene blue, chlorhexidine gluconate, or a c...
What is the current status of trial NCT05797818?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 28 participants. The study started on 2023-01-10. Estimated completion is 2023-02-08.
What interventions are being tested in trial NCT05797818?
The interventions under investigation include: Methylene Blue Only (DEVICE), Chlorhexidine Gluconate Only (DEVICE), Methylene Blue + Chlorhexidine Gluconate (DEVICE), Light Only (DEVICE).
Who is sponsoring clinical trial NCT05797818?
This trial is sponsored by Ondine Biomedical, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.